Early Access — free while we kick the tires
EdgarHawk

Neil J Fernandes

Senior Vice President

Officer

Latest: Senior Vice President selling · May 2026

4 filings analyzed · 1 company · Latest 2026-06-02

Never miss a filing from Neil J Fernandes

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
LAM RESEARCH CORP LRCX 0 4 Net selling

Activity

June 2026
2026-06-02 LAM RESEARCH CORP LRCX 10b5-1 Plan
low
Sell
7,659 shares
$2,371,226
Significance 4/10

SVP Neil J Fernandes sold 7,659 shares of LRCX at $309.60 (total $2.4M); post-sale holdings 58.5K shares under 10b5-1 plan.

Neil J Fernandes executed a scheduled sale of 7,659 shares under a 10b5-1 trading plan adopted on 2025-11-17, reducing his LRCX holdings by -11.6% to 58.5K shares. The stock traded at $309.60 on 2026-06-01 and currently sits at $332.22, near its 52-week high of $333.33. His prior LRCX sales on 2026-05-01 and 2024-07-12 show divergent outcomes: the May 2026 sale saw subsequent price appreciation (+24.7% in 30 days), while the July 2024 and June 2024 sales preceded sharp declines of -92.4% and -91.5% respectively. As a pre-arranged transaction, the timing reflects the plan's schedule rather than discretionary market judgment.

May 2026
2026-05-04 LAM RESEARCH CORP LRCX 10b5-1 Plan
medium
Sell
18,170 shares
$4,635,894
Significance 4/10

SVP Neil Fernandes sells ~$4.6M in LAM shares, trimming position by over one-fifth at elevated valuation.

Neil Fernandes, a Senior Vice President at LAM Research, sold roughly one-fifth of his shareholdings in a single transaction, raising approximately $4.6 million. The sale occurred when the stock was trading near the middle of its recent range—down slightly from all-time highs but still benefiting from strong momentum over recent months. As a C-suite officer with direct operational insight into the company, his decision to trim a substantial block of shares warrants attention, particularly given that the company's financial position remains strong with healthy profitability and growing revenue. However, the sale is not dramatic enough to suggest panic; rather, it appears consistent with a disciplined officer rebalancing a concentrated position or taking gains after a period of appreciation. The timing and size merit observation, though this is not uncommon for senior executives managing their personal wealth after periods of strong stock performance.

July 2024
2024-07-15 LAM RESEARCH CORP LRCX 10b5-1 Plan
low
Sell
1,620 shares
$1,712,324
Significance 3/10

LRCX: Senior VP Fernandes sells 1,620 shares ($1.7M) under pre-arranged 10b5-1 plan adopted Feb 2024

Fernandes Neil J, Senior Vice President, sold 1,620 shares of LAM RESEARCH CORP (LRCX) at $1,056.99 on 2024-07-12 for a total value of $1,712,323.80, reducing his holdings from 6,857 shares to 5,237 shares. This sale was executed under a pre-arranged 10b5-1 trading plan adopted on 2024-02-23, meaning it is scheduled and not discretionary—the timing and volume were predetermined months in advance rather than reflecting any contemporaneous judgment about the stock. The 23.6% reduction in his holdings through this scheduled transaction is a routine administrative execution of a planned trading program, not an indicator of insider sentiment or conviction regarding current market conditions.

2024-07-01 LAM RESEARCH CORP LRCX 10b5-1 Plan
low
Sell
4,409 shares
$4,654,846
Significance 4/10

SVP Fernandes sells 4,409 LRCX shares ($4.7M) via scheduled 10b5-1 plan; retains 6,857 shares post-sale.

Senior Vice President Neil J Fernandes executed a sale of 4,409 shares at $1,055.76 on 2024-06-27 as part of a pre-arranged 10b5-1 trading plan adopted on 2024-02-15. This is a scheduled, non-discretionary transaction, so no timing signal can be inferred. The sale reduced his holdings from 11,266 shares to 6,857 shares, representing a 39.1% reduction in his position. The $4,654,845.84 proceeds indicate meaningful liquidity but do not establish a conviction-based signal given the plan's mechanical execution framework.

Related insiders